Day 1: June 18, 2026 
Laying the Foundation for the Establishment of a National Strategy for CGP Readiness

Conference Day 1 Opening

‍Cassandra Macaulay, B.Sc., MHS, RTNM, Chief Research Officer, CCRAN 
‍

Welcome from CCRAN’s President & CEO

Filomena Servidio-Italiano, Hon B.Sc., B.Ed., M.A., President & CEO, CCRAN   
Eric Hamilton, Stage IV Colorectal Cancer Patient; Patient Advocate  
‍

Key Learnings from CCRAN's 2025 Biomarkers Conference

Dr. Stephanie Snow, MD, FRCPC, Medical Oncologist, QEII Health Sciences Centre; Professor, Dalhousie University 
‍

Economic and Health System Readiness: Leveraging Evidence to Support Comprehensive Genomic Profiling Integration Across Canada

Don Husereau, B.Sc. Pharm, M.Sc., Adjunct Professor of Medicine, University of Ottawa
Eddy Nason, MPhil, B.Sc., Director, Health, Signal49 Research
‍

CDA's Framework for Equitable Biomarker Testing Access: Key Recommendations and Future Directions

Dr. Laura Weeks, Ph.D., Director, Health Technology Assessment, Canada's Drug Agency
‍

Stakeholder Reflections on CDA’s Assessment Framework for Cancer Biomarkers: A Cross-Sector Dialogue

Bill Dempster, President, 3Sixty Public Affairs
Dr. Catalina Lopez-Correa, MD, Ph.D., Breast Cancer Survivor and Advocate; Vice-Chair, Global Genomics Network for Education and Training (GGNET); Co-Chair, Patient Working Group, Marathon of Hope Cancer Centres Network
Cassandra Macaulay, B.Sc., MHS, RTNM, Chief Research Officer, CCRAN
Dr. Laura Weeks, Ph.D., Director, Health Technology Assessment, Canada's Drug Agency
Dr. Sharlene Gill, MD, MPH, MBA, FASCO, Professor of Medicine, UBC; Medical Oncologist, BC Cancer - Vancouver; Medical & Scientific Advisory Board Co-Chair, Colorectal Cancer Resource & Action Network (CCRAN)
Laura Greer, Patient Expert; Executive Vice President, Health & Wellness, Burson Canada; Breast Cancer Advocate
‍

The Patient Voice Amplified: CGP Making a Difference in the Canadian Cancer Care Landscape Across Tumour Types

Eva Villalba, MBA, M.Sc., VBHC Green Belt; Executive Director, Quebec Cancer Coalition; President, VBHC Learning Community
Corri Desaulniers, Stage IV Cholangiocarcinoma Patient, FGFR2 Fusion; Patient Partner & Advocate, Canadian Cholangiocarcinoma Collaborative (C3)
Mariana Markovic, RN, MN, MHSC, CHE, Stage IV Colon Cancer Survivor; Healthcare Consultant, Independent Healthcare Consulting Inc.; Patient Advocate
Laura Greer, Patient Expert; Breast Cancer Advocate; Executive Vice President, Health & Wellness, Burson Canada
Dr. Mary K. Bryson, Ph.D., Stage IV EGFR Lung Cancer Patient; International Association for the Study of Lung Cancer (IASLC) STARS Scholar Patient Advocate; Professor, Department of Language and Literacy Education (LLED), Faculty of Education, The University of British Columbia
Brad Sluiter, Stage IV Pancreatic Cancer Patient
‍

Molecular Tumour Boards in Practice: Advancing Standardization and System Readiness

Dr. Michael Raphael, MD, FRCPC, Medical Oncologist, Early Age Onset CRC Cancer Clinic Lead, Odette Cancer Centre, Sunnybrook Health Sciences Centre; Co-Chair, Medical & Scientific Advisory Board, CCRAN
Jennifer Willis, Caregiver to spouse diagnosed with Stage IIIC Cholangiocarcinoma
Dr. Alan Spatz, MD, M.Sc., Professor, Departments of Pathology & Oncology, McGill University; Chief, Department of Clinical Laboratory Medicine, MUHC; Medical Director, Optilab Montreal-MUHC Network
Prof. Arndt Vogel, MD, Ph.D., Clinician Scientist, Division of Gastroenterology and Hepatology, Toronto General Hospital & Medical Oncology, Princess Margaret Cancer Centre; Professor of Medicine, University of Toronto
Dr. Erin DeBruin, Manager, Professional Education and Implementation, Genome BC
Dr. Shantanu Banerji, B.Sc. (Med), MD, FRCPC, Co-Chair, Expert Steering Committee; Director of Precision Oncology and Advanced Therapeutics, CancerCare Manitoba
‍

Driving Access Through Partnership: The Role of Industry in Canada’s Precision Oncology Landscape

Dr. Georgia Balsevich, Ph.D., Senior Sector Innovation Manager, Genome Alberta
Don Wood, Caregiver to spouse who succumbed to Stage IV Colorectal Cancer; Community & Patient Engagement Specialist, CCRAN
Dr. André Galarneau, M.Sc., Ph.D., Executive Director & Vice-President, Oncology Business Unit, Merck Canada Inc.
Tracey Taylor, Hons BA, CCPE, Strategic Healthcare Partner — Ontario, Johnson & Johnson Innovative Medicines
Mark Oatway, Head, Diagnostics and Transforming Care, Oncology, AstraZeneca Canada
Hon. John Wilkinson, Former Ontario Minister of Research & Innovation
Dr. Michael Mengel, MD, Professor, Department of Laboratory Medicine & Pathology, University of Alberta; Director, Alberta Transplant Institute; North Sector Medical Director, Alberta Precision Laboratories (APL)
‍

Glance at Day 2. Closing Remarks from CCRAN’s President & CEO

Filomena Servidio-Italiano, Hon B.Sc., B.Ed., M.A., President & CEO, CCRAN
‍

Day 2: June 19, 2026 
Advancing the Vision: Leveraging Clinical Evidence and the Patient Voice

Conference Day 2 Opening

Cassandra Macaulay, B.Sc., MHS, RTNM, Chief Research Officer, CCRAN 
‍

Welcome to Day 2 from CCRAN’s President & CEO

Filomena Servidio-Italiano, Hon B.Sc., B.Ed., M.A. , President & CEO, CCRAN 
‍Michelle Audoin, Chair, Patient Representative Committee, Canadian Cancer Trials Group (CCTG); Patient Advocate and Community Collaborator; All.Can Canada Evidence Working Group; Stage IV Breast Cancer and Thyroid Cancer Patient
‍

A National Conversation on CGP Becoming a Standard of Care

Dr. Monika Krzyzanowska, MD, MPH, FRCPC, FASCO, Co-Chair, Expert Steering Committee; Chief & Medical Oncologist, Odette Cancer Centre, Sunnybrook Health Sciences Centre; Regional Vice President, Ontario Health (Cancer Care Ontario); Professor of Medicine, University of Toronto
Neil Marr, Hon B.A., Caregiver to spouse who succumbed to Stage IV Cholangiocarcinoma; Research Advocate and Mentor; Patient Partner with PanCuRx
Dr. Mita Manna, MD, FRCPC, Medical Oncologist, Saskatoon Cancer Centre; Associate Professor, Department of Oncology, University of Saskatchewan
Dr. Stephanie Snow, MD, FRCPC, Medical Oncologist, QEII Health Sciences Centre; Professor, Dalhousie University
Dr. Rebecca Auer, MD, M.Sc., FRCSC, FACS, Executive Vice-President, Research & Innovation, The Ottawa Hospital; CEO & Scientific Director, Ottawa Hospital Research Institute; Professor, Departments of Surgery, Biochemistry, Immunology & Microbiology, University of Ottawa
Dr. Shantanu Banerji, B.Sc. (Med), MD, FRCPC, Co-Chair, Expert Steering Committee; Director of Precision Oncology and Advanced Therapeutics, CancerCare Manitoba
Dr. Yoo-Joung Ko, MD, MMS, M.Sc., Medical Oncologist, St. Michael's Hospital, Unity Health; Medical Director, Cancer & Endoscopy Program, Unity Health
Dr. Urban Emmenegger, MD, Medical Oncologist, Odette Cancer Centre, Sunnybrook Health Sciences Centre; Associate Professor, Department of Medicine, University of Toronto
Dr. Jason Karamchandani, MD, Associate Professor, Departments of Pathology, Neurology and Neurosurgery, McGill University; President, Canadian Association of Pathologists
‍

Unlocking the Research Pipeline: Bridging Clinical Trials and Real-World Genomics

Dr. Stéphanie Michaud, Ph.D., President & CEO, BioCanRx
‍Dillan Eisenhaur, Stage IV Colorectal Cancer Patient; Founder, Second Look Cancer Inc.
‍Dr. Yvonne Bombard, Ph.D., Canada Research Chair, Genomics Health Services & Policy, Unity Health Toronto; Professor, University of Toronto; Director, Genomics Health Services Research Program, St. Michael's Hospital; Co-Founder & CEO, Genetics Adviser
‍Dr. Jim Woodgett, President and Scientific Director, The Terry Fox Research Institute (TFRI)
‍Dr. Arvind N. Dasari, MD, Director of Clinical Research, Dept. of GI Medical Oncology, University of Texas MD Anderson Cancer Center, USA
‍

Patient Group Reflections on the Case for CGP Investment

Filomena Servidio-Italiano, Hon. B.Sc., B.Ed., M.A., President & CEO, CCRAN
‍Ayelet Borgida, M.Sc., Director of Medical and Health Initiatives, Pancreatic Cancer North America
‍Lindsay Timm, Executive Director, Canadian Cancer Survivor Network (CCSN)
‍Winky Yau, Manager, Medical Affairs, Lung Cancer Canada
‍Teresa Norris, Sexual Health Specialist; Founder & President, HPV Global Action
‍JK Miller, Health Policy & Advocacy Lead, Canadian Breast Cancer Network
‍Laz Bouros, President, Thyroid Foundation of Canada
‍Austin Zimmer, B.Sc., M.Sc., Support Services Manager & Research Coordinator, Prostate Cancer Foundation Canada
‍Shannon Phillips, BSW, Locally Advanced Triple-Negative Breast Cancer & Gastric Cancer Survivor; Board Member, My Gut Feeling — Stomach Cancer Foundation of Canada
‍

Scaling What Matters: Building on Economic Evidence to Help Inform Policy

Dr. Étienne Richer, Ph.D., Director of Genomics Programs, Genome Canada
‍‍Steve Slack, Stage IV Colon Cancer Survivor‍
Eddy Nason, MPhil, B.Sc., Director, Health, Signal49 Research
‍Matthew Brougham, Senior Global Consultant, Certara Evidence & Access; President & CEO, Brougham Consulting Inc.
‍Dr. Steven Narod, MD, Senior Scientist, Women's College Hospital Research Institute; Professor, Dalla Lana School of Public Health and Department of Medicine, University of Toronto
‍Dr. Sandeep Sehdev, MD, FRCPC, Medical Oncologist & Assistant Professor, The Ottawa Hospital Cancer Centre; Associate Professor of Medicine, University of Ottawa
‍

From Laboratory Readiness to Patient Impact: Why CGP Falls Short and What Must Change

Andrea Tjahja, MLT, ART, B.Sc., B.Ed., Vice President, Operations, Medical Laboratory Professionals' Association of Ontario (MLPAO)
‍Dr. Christine Qiong Wu, M.Sc., Ph.D., Stage IV Lung Cancer Patient; Professor of Engineering, University of Manitoba
Michelle Audoin, Chair, Patient Representative Committee, Canadian Cancer Trials Group (CCTG); Patient Advocate and Community Collaborator; All.Can Canada Evidence Working Group; Stage IV Breast Cancer and Thyroid Cancer Patient
‍Craig Ivany, B. Comm, MBA, CHE, ICD.D, Adjunct Professor, Pathology and Laboratory Medicine, University of British Columbia
Andrea Beharry, Manager, Clinical Services, Advanced Diagnostics, William Osler Health System
Dr. Jason Karamchandani, MD, Associate Professor, Departments of Pathology, Neurology and Neurosurgery, McGill University; President, Canadian Association of Pathologists
Prof. Brenda Gamble, Ph.D., Associate Professor, Faculty of Health Sciences and Program Director, Bachelor of Health Administration & Allied Health Sciences, Ontario Tech University
‍

Day 2 Closing Remarks and Conference Adjournment

Filomena Servidio-Italiano, Hon B.Sc., B.Ed., M.A., President & CEO, CCRAN 
‍